Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.452 USD | +7.41% | +6.25% | -69.04% |
Apr. 08 | RedHill Biopharma Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Mar. 28 | RedHill Biopharma Ltd. cancelled the transaction announced on March 8, 2023 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
-69.04% | 13.41M | |
-5.99% | 84.46B | |
+2.76% | 40.85B | |
-24.88% | 27.69B | |
+53.61% | 24.28B | |
-8.08% | 17.09B | |
-33.74% | 13.67B | |
-16.63% | 11.86B | |
-11.19% | 11.79B | |
-2.25% | 8.07B |
- Stock Market
- Equities
- RDHL Stock
- News RedHill Biopharma Ltd.
- Redhill Biopharma : AstraZeneca, Nektar Therapeutics Settle Movantik Patent Litigation with Aurobindo